How hematopoietic stem cells (HSCs) coordinate the regulation of opposing cellular mechanisms such as self-renewal and differentiation commitment remains unclear. Here we identified the transcription factor and chromatin remodeler Satb1 as a critical regulator of HSC fate. HSCs lacking Satb1 had defective self-renewal, were less quiescent and showed accelerated lineage commitment, which resulted in progressive depletion of functional HSCs. The enhanced commitment was caused by less symmetric self-renewal and more symmetric differentiation divisions of Satb1-deficient HSCs. Satb1 simultaneously repressed sets of genes encoding molecules involved in HSC activation and cellular polarity, including Numb and Myc, which encode two key factors for the specification of stem-cell fate. Thus, Satb1 is a regulator that promotes HSC quiescence and represses lineage commitment.
A r t i c l e s
In metazoans, adult tissue-specific stem cells constitute a rare population of long-lived cells with the ability to give rise to many differentiated cell types. Hematopoietic stem cells (HSCs) ensure the life-long generation of all cells of the innate and adaptive immune systems, as well as red blood cells and platelets 1 . Like many other tissue-specific stem cells in multicellular organisms, HSCs have key features that separate them functionally from differentiated cell types, including relative cellular quiescence, self-maintenance and multilineage differentiation ability 2, 3 . Balancing the self-renewal and differentiation of HSCs is crucial for long-term maintenance of the pool of functional HSCs and thus for their ability to sustain blood-cell production and regeneration 4 . Alterations in the balance of quiescence and activation, self-renewal and differentiation are known to exhaust HSCs 5 or lead to their malignant transformation 6 .
Transcriptional regulation by specific factors is critical for ensuring the appropriate function of both embryonic and adult tissue-specific stem cells, in part by governing their ability to self-renew and differentiate 7 . The interaction of transcriptional programs, rather than the individual transcription factors themselves, determines the entire set of stem-cell functions, including fate 'decisions' 8, 9 . However, how individual functions such as stem-cell quiescence, division and lineage commitment are coordinately regulated is only beginning to be understood. Global epigenetic regulation has been shown to have an important role in the function and lineage differentiation of stem cells, including HSCs 8, 10, 11 . However, it is still largely unknown how specific epigenetic factors affect and integrate the activation and repression of genes of various transcriptional programs in stem cells.
Satb1 ('special AT-rich sequence-binding protein 1') was identified as a chromatin organizer that forms cage-like chromatin networks in the nucleus of precursors of T cells, tethering together specific DNA sequences and regulating the expression of several genes that encode molecules relevant for T cell maturation [12] [13] [14] . Satb1 also functions in the differentiation of other hematopoietic lineages 15 and embryonic stem cells by controlling the expression of genes enoding transcriptional master regulators, such as Sfpi1 (ref. 15) or Nanog 16 . Several studies have also linked Satb1 with cancer. Enhanced activity of this epigenetic factor is able to reprogram transcriptional networks and promote aberrant growth and metastasis in various types of epithelial tumors [17] [18] [19] . Additionally, impairment of Satb1 is associated with a subtype of acute myelogenous leukemia 15 . The role of Satb1 in tissuespecific stem cells, including HSCs, has not been examined thus far.
Here we investigated the role of Satb1 in HSCs and found that Satb1 critically mediated many functionally linked HSC properties. Satb1 was crucial for the maintenance of HSC self-renewal and exerted its function by simultaneously regulating transcriptional programs associated with the cell-polarity factor Numb, the stem-cell regulator c-Myc and several cell-cycle regulators, and thereby promoted the quiescence and repressed the lineage commitment of HSCs.

RESULTS
Satb1 deficiency impairs the long-term repopulation ability of HSCs
To characterize the expression of Satb1 mRNA and Satb1 protein in immature hematopoietic cells, we purified mouse HSCs (CD150 + lineage-negative (Lin − ) c-Kit + Sca-1 + (LSK)), multipotent progenitor cells (MPPs; CD150 − LSK), common myeloid progenitor cells (CMPs; CD34 + FcγRII/III − c-Kit + Sca-1 − Lin − ), granulocytic-monocytic progenitor cells (GMPs; CD34 + FcγRII/III + c-Kit + Sca-1 − Lin − ) and megakaryocytic-erythroid progenitor cells (MEPs; CD34 − FcγRII/ III − c-Kit + Sca-1 − Lin − ) and analyzed them by quantitative RT-PCR and immunohistochemistry (sorting strategy, Supplementary Fig. 1a) . We found high expression of Satb1 mRNA and Satb1 protein in thymocytes and well-detectable expression of these in all bone marrow-derived stem cells and progenitor cells (Fig. 1a,b) . Among the immature hematopoietic cell populations, Satb1 expression was highest in the HSC, MPP and CMP compartments and lower in lineage-restricted GMPs and MEPs. Satb1 was located in the nucleus in HSCs, as assessed by confocal microscopy (Fig. 1c) . Satb1 has been reported to be present in the nucleus of thymocytes and has been shown to act as a transcriptional regulator 20, 21 .
To assess the role of Satb1 in HSC function, we examined the multilineage reconstitution and long-term self-maintenance ability of HSCs through the use of a Satb1 −/− mouse model in which the first five of eleven exons (which encode 213 amino acids), including the translation start codon, are eliminated, which results in a complete lack of Satb1 protein 12 . We first characterized fetal hematopoiesis, as homozygous Satb1 −/− mice die around the time of birth. Flow cytometry showed a normal frequency of HSCs, MPPs, CMPs, GMPs and MEPs in the fetal liver at embryonic days 17-18.5 (E17-18.5; Supplementary Fig. 1b) . Colony assays showed that Satb1 −/− fetal livers had significantly more functional colony-initiating progenitors of the granulocytic-monocytic lineage (2.2-fold ± 0.6-fold;), erythroid lineage (4.3-fold ± 1.9-fold) and monocytic lineage (15.5-fold ± 7.1-fold) than did wild-type livers (P < 0.05; Supplementary Fig. 1c ). Noncompetitive transplantation of Satb1 −/− and wild-type fetal liver cells into wild-type congenic mice resulted in similar hematopoietic reconstitution 24 weeks after transplantation (Supplementary Fig. 1d ) with no significant effect on the reconstitution of mature myeloid cells, erythroid cells or B cells (Fig. 1d,e) ; we found only slightly fewer CD4 + T cells, consistent with published observations 12 . The frequency of functional HSCs in fetal livers at E17-18.5 was also not significantly altered by the absence of Satb1, as determined by competitive limiting-dilution transplantation assays (P > 0.05; Supplementary  Fig. 1e ). These findings showed that during embryogenesis, Satb1 was not essential for the generation of HSCs or for their short-term multilineage repopulation capacity.
To evaluate the long-term self-renewal ability of HSCs in the absence of Satb1, we did competitive serial transplantation experiments 22 . Unfractionated Satb1 −/− cells from the fetal liver showed a progressive repopulation defect in serial competitive transplantations, with 42% ± 2.4% less repopulation than that of wild-type cells in the second reconstitution, 71.3% ± 12.9% less repopulation in the third transfer and 91.3% ± 2.7% less repopulation in the fourth serial transfer ( Fig. 1f and  Supplementary Fig. 2a ). Serial transplantation of purified Satb1 −/− HSCs also showed a progressive loss of repopulation ability relative to that of wild-type HSCs, with a 44% ± 15% less repopulation in the second serial transfer and 69% ± 25% less repopulation in the third serial transfer (Fig. 1g and Supplementary Fig. 2b) . Characterization of the repopulation of various cell lineages showed a reconstitution impairment in all compartments (Supplementary Fig. 2c ), indicative of a defect at the stem-cell level. Together these data showed that Satb1 was indispensable for the long-term self-renewal of HSCs (Fig. 2a,b) as well as the HSC compartment (Fig. 2c) . In both stem cell-containing populations, there were significantly fewer quiescent cells in the G0 phase of the cell cycle in the absence of Satb1 (Fig. 2b,c) . However, most apparent differences in cell-cycle distribution were in the purified HSC population; 36% ± 4.5% of Satb1 −/− HSCs were in G0, compared with 53.5% ± 2.1% wild-type HSCs, whereas significantly more Satb1 −/− HSCs (63% ± 5.7%) than wild-type HSCs (42.5% ± 3.5%) were in G1 Fig. 2c ). Consistent with that, the alteration in cellcycle activity was accompanied by a change in cell-division kinetics. In experiments with individually sorted, highly enriched HSCs (CD150 + CD48 − LSK HSCs), significantly fewer Satb1 −/− HSCs (5% ± 2.4%) than wild-type HSCs (20.7% ± 3.4%) remained in an undivided state, whereas significantly more Satb1 −/− HSCs (77.5% ± 1.2%) than wild-type HSCs (61.5% ± 1.2%) divided once after 48 h in an ex vivo culture assay (Fig. 2d) . Consistent with that, we found that Satb1 expression in wild-type HSCs was dependent on the cell-cycle phase, with highest Satb1 expression in cells in G0 ( Supplementary  Fig. 2d ). Satb1 expression in HSCs was much lower after HSC activation in vivo after treatment with 5-fluorouracil than in nonactivated HSCs at steady state ( Supplementary Fig. 2e ). Together these results indicated that Satb1 promoted the quiescence of HSCs under steadystate as well as stress conditions.
Greater differentiation commitment of Satb1-deficient HSCs
To further elucidate the functional alterations of adult Satb1 −/− HSCs, we characterized the composition of the HSC (CD150 + CD48 − LSK) and MPP (CD150 − CD48 + LSK) compartments of wild-type and Satb1 −/− cells after competitive congenic transplantation into BL6/ SJL mice. Recipients of unfractionated Satb1 −/− fetal liver cells had a significantly lower frequency of HSCs (4.2% ± 3.6%) than did recipients of wild-type cells (13.9% ± 11.6%) and had a significantly higher frequency of MPPs (77.5% ± 12.9%) than did recipients of wild-type cells (61.4% ± 16.9%; total nucleated bone marrow cells) than did recipients of wild-type cells (Fig. 3c) .
To determine if Satb1 −/− HSCs were more prone to commit to differentiation, we evaluated the colony-formation capacity of fractionated CD150 + CD48 − LSK cells, CD150 + CD48 + LSK cells and CD150 − CD48 + LSK MPPs. Satb1 −/− CD150 + CD48 − LSK cells formed 1.6-fold more erythroid burst colony-forming units (BFU-E), 1.9-fold more granulocyte-monocyte colony-forming units (CFU-GM) and 1.8-fold more granulocyte-erythrocyte-monocyte-megakaryocyte colony-forming units (CFU-GEMM) than did their wild-type counterparts (Fig. 3d) . Similarly, Satb1 −/− CD150 + CD48 + LSK cells also showed 1.7-fold more generation of CFU-GM, 1.8-fold more generation of CFU-G or M and 1.6-fold more generation of CFU-GEMM than did their wild-type counterparts (Fig. 3e) . That enhanced formation of myeloid colonies by Satb1 −/− cells was restricted to the HSC compartments, as we did not observe a substantial difference in the colony formation of Satb1 −/− MPPs versus wild-type MPPs (Fig. 3f) . These findings suggested that Satb1 suppressed differentiation commitment specifically in HSCs.
To further assess the role of Satb1 in HSC commitment, we modified a published method for tracing cell divisions in stem cells and progenitor cells in vivo 25 . Here, we purified donor-derived Satb1 −/− and wild-type CD150 + LSK cells from long-term-reconstituted recipient mice and labeled them with the cell-division tracer CMFDA. We then transplanted those cells into a second cohort of sublethally irradiated recipients and assessed them by monitoring the division and expression of the signaling-lymphocytic-activation-molecule family member CD150 of individual donor-derived HSCs (Fig. 4a) . We used CD150 as a marker because it has been shown that HSCs downregulate CD150 expression after commitment to differentiation 26, 27 . Applying this strategy, we found that Satb1 −/− CD150 + LSK HSCs downregulated CD150 expression after fewer cell divisions after transplantation relative to the downregulation of its expression by wild-type HSCs (Fig. 4a,b) . After two divisions, 54.3% ± 15.5% of Satb1 −/− HSCs versus 81.2% ± 12.5% of wild-type HSCs still expressed CD150. After three divisions, 28.6% ± 11.4% of the Satb1 −/− HSCs versus 48.8% ± 7.4% of the wild-type HSCs expressed CD150 (Fig. 4b) . These observations indicated that HSC commitment was quantitatively greater in the absence of Satb1.
Satb1 regulates the fate of HSCs by modulating the division mode
The impairment of long-term-repopulation capacity and the greater commitment of Satb1 −/− HSCs led us to hypothesize that Satb1 regulates the division mode of HSCs by promoting symmetric self-renewal divisions and repressing differentiation divisions. To assess this, we quantified symmetric and asymmetric divisions in individual Satb1 −/− and wild-type HSCs by staining the cell-fate determinant and polarity factor Numb as described before 28, 29 . Higher expression of Numb protein in one of two daughter cells indicated asymmetric division and high Numb expression in both daughter cells showed symmetric differentiation division, whereas sustained low expression of Numb in both daughter cells marked symmetric self-renewal divisions (Fig. 4c) . We quantified the division types of individual HSCs and found that Satb1 −/− HSCs underwent significantly fewer symmetric self-renewal divisions (5.2% ± 5.4%) than did wild-type HSCs (32.4% ± 7.2%; a difference of 6.2-fold), whereas Satb1 −/− HSCs underwent significantly more symmetric differentiation divisions (61.4% ± 5.5%) 
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A r t i c l e s than did wild-type HSCs (35.2% ± 13.5%; Fig. 4d ). These observations showed that Satb1 promoted the self-renewal and suppressed the differentiation commitment of HSCs by regulating the type of stem-cell division.
Satb1 regulates Notch targets through repression of Numb in HSCs
Regulation of Numb has been reported mainly at the protein level 30, 31 ; Numb has also been found to be transcriptionally regulated in Drosophila sensory bristle cells 32 . Transcriptional or epigenetic regulation of Numb in mammalian stem cells is unknown. We found twofold higher Numb mRNA expression in Satb1 −/− CD150 + CD48 − LSK HSCs than in their wild-type counterparts (Fig. 4e) . Numb is a negative regulator of Notch signaling that has been reported to modulate cell-fate 'decisions' of HSCs 30, 31 . We therefore assessed whether the higher Numb expression in the absence of Satb1 had an effect on the transcription of genes targeted by Notch. We found that Satb1 −/− CD150 + LSK HSCs, as well as highly purified Satb1 −/− CD150 + CD48 − LSK HSCs, had significantly lower expression of Notch targets, including Hes1 (60% ± 13%), Hes5 (82.5% ± 6.6%), Dtx1 (88.5% ± 19.4%) and Hey1 (83.4% ± 9.2%), than did their wild-type counterparts ( Fig. 4f and Supplementary Fig. 3a,b) . To further assess whether Numb was downstream of Satb1 and whether higher Numb expression was functionally critical for the altered fate of Satb1 −/− HSCs, we did 'rescue' experiments ( Fig. 4g,h ). Ectopic re-expression of Satb1 in Satb1-deficient HSCs to expression similar to that in wild-type HSCs led to restoration of Numb expression as well as of Hes1 expression ( Fig. 4g and Supplementary Fig. 3c ). Moreover, short hairpin RNA (shRNA)-mediated knockdown of the higher expression of Numb in Satb1 −/− CD150 + CD48 − LSK HSCs by 60% ± 3.1% led to a significant decrease in the greater abundance of colony-initiating cells by diminishing the CFU-GEMM (58.2% ± 6.7%), CFU-GM (45.8% ± 2%) and BFU-E (30% ± 8%) compared with that of cells transduced with nontargeting control shRNA ( Fig. 4h and Supplementary Fig. 3d ). Consistent with that observation, the expression of Hes1, Hes5 and Dtx1 was de-repressed in Satb1 −/− CD150 + CD48 − LSK cells expressing Numb-specific shRNA relative to the expression of those genes in their counterparts transduced with nontargeting control shRNA (2.9-fold ± 0.2-fold, 2.8-fold ± 0.4-fold and 4.3-fold ± 0.8-fold, respectively; Supplementary Fig. 3e) . Notably, shRNA-mediated knockdown of Numb in wild-type HSCs did not cause a significant change in the number of colony-initiating cells (Fig. 4h) . These results demonstrated that Satb1 modulated the fate determination of HSCs at least in part by regulating Numb expression and Notch signaling. The finding that downregulation of Numb was sufficient to 'rescue' the enhanced differentiation commitment of Satb1 −/− HSCs but did not have an effect on wild-type HSCs suggested that additional mechanisms contributed to the changes in the fate of Satb1-deficient HSCs.
Satb1 deficiency alters transcriptional networks in HSCs
To obtain insight into potential cooperating factors that contributed to the enhanced differentiation commitment of Satb1- Fig. 4a) . We confirmed the altered expression of a subset of genes from both categories by real-time PCR analysis of an independent set of samples. We confirmed significant overexpression in Satb1 −/− HSCs (relative to expression in wild-type HSCs) of genes encoding molecules involved in cell-cycle activation (Rbbp9, 3.5-fold ± 1-fold; Kdm3a, 2.2-fold ± 0.3-fold; Chaf1a, 3.9-fold ± 1.4-fold; and Bgn, 31.1-fold ± 5-fold) and genes encoding molecules that regulate cellular organization and contribute to cellular polarity (Iptr1, 2.1-fold ± 0.46-fold; and Tnik, 1.8-fold ± 0.2-fold; P <0.05; Supplementary  Fig. 4b ). These data showed that Satb1 regulated various functional gene networks in HSCs that were supportive of the observed phenotype of enhanced cell-cycle activity and differentiation commitment of Satb1 −/− HSCs. Gene-set enrichment analysis 33 of genes expressed differently in Satb1 −/− HSCs relative to their expression in wild-type HSCs identified a core set of genes directly targeted by c-Myc 34 with greater abundance in Satb1 −/− HSCs (normalized enrichment score, 1.90; nominal P value, <0.001; Fig. 5a and Supplementary Fig. 4c) . Quantitative real-time PCR showed overexpression in Satb1 −/− CD150 + CD48 − LSK HSCs (relative to expression in wild-type HSCs) of several targets of c-Myc, including Igf1R (2.9-fold ± 0.2-fold), Clasp1 (26.1-fold ± 3.0-fold), Tlr4 (1.9-fold ± 0.2-fold) and Uhrf2 (1.47-fold ± 0.2-fold; (Fig. 5d) . These data showed that Satb1 regulated transcriptional networks involved in cell-cycle regulation and cellular organization in HSCs.
Greater Myc activity in Satb1 −/− HSCs To determine whether the Satb1-dependent increase in c-Myc activity was functionally relevant in Satb1 −/− HSCs, we treated Satb1-deficient CD150 + CD48 − LSK HSCs with two different smallmolecule inhibitors of c-Myc (10058-F4, shown to specifically interfere with c-Myc transactivation 35 , and JQ1, a bromodomain-BRD4 inhibitor that causes direct repression of Myc transcription 36 ) and assessed colony-initiating capacity. Both 10058-F4 and JQ1 impaired the expression of genes targeted by c-Myc ( Supplementary  Fig. 5a,b) and the colony formation of Satb1-deficient HSCs (Supplementary Fig. 5c,d ) in a dose-dependent manner. We then assessed the effect of a low effective inhibitor concentration (15 µM 10058-F4 and 250 nM JQ1) on Satb1 −/− and wild-type HSCs. We found less generation of CFU-GEMM (39% ± 1.9%) CFU-GM (48.9% ± 8%) and BFU-E (45% ± 2.8%) by Satb1-deficient HSCs treated with 10058-F4 than by their counterparts treated with DMSO (dimethyl sulfoxide) and less generation of CFU-GEMM (56.8% ± 1.9%), CFU-GM (51% ± 5.6%) and BFU-E (47.2% ± 2.7%) by Satb1-deficient HSCs treated with JQ1 than by their DMSO-treated counterparts (Fig. 5e,f) , which demonstrated 'rescue' of the greater abundance of colony-forming units. We did not observe an effect of these inhibitors on wild-type CD150 + CD48 − LSK HSCs (Fig. 5e,f) . These results showed that greater c-Myc activity was functionally important in Satb1 −/− HSCs. Of note, Numb expression was not significantly altered after treatment of Satb1 −/− HSCs with inhibitors of c-Myc (P >0.05; Supplementary Fig. 5e ).
Widespread epigenetic changes in Satb1-deficient HSCs
We assessed whether Satb1 binds to the promoter regions of Numb and Myc in HSCs by chromatin immunoprecipitation (ChIP) with a hematopoietic stem cell line (HPC7) 37 . We found that Satb1 bound npg A r t i c l e s to chromatin upstream of the transcriptional start sites of Numb and Myc (Fig. 6a,b and Supplementary Fig. 6a,b) . As Satb1-dependent gene regulation has been linked to epigenetic modifications, such as histone modifications and DNA cytosine methylation 16, 21 , we analyzed permissive (H3K4me3) and repressive (H3K27me3) histone marks at the Numb and Myc promoters. ChIP of primary Satb1 −/− and wild-type HSCs showed that in the absence of Satb1, there were significantly more H3K4me3 marks at the promoter regions of both Numb and Myc (Fig. 6c,d ), in line with the higher expression of Numb and Myc in Satb1 −/− HSCs.
We further evaluated genome-wide DNA cytosine methylation by enhanced reduced representation bisulfite sequencing (ERRBS) of DNA extracted from sorted HSCs and MPPs. We found significant differences between Satb1 −/− HSCs and wild-type HSCs in DNA cytosine methylation, with a total of 11,924 differently methylated regions (DMRs; 1-kilobase genomic tiles with no overlap) composed of 5,089 hypomethylated DMRs and 6,835 hypermethylated DMRs in Satb1 −/− HSCs relative to their methylation in wild-type HSCs (Fig. 6e and  Supplementary Table 2 ). DMRs associated with Satb1 −/− HSCs were located mainly in CpG islands and isolated CpGs, without a strong 
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A r t i c l e s 'preference' for a presence in specific genomic regions, but with a slightly greater abundance of DMRs in intergenic regions (Fig. 6f) .
Next we compared wild-type HSCs and wild-type MPPs to define methylation changes associated with normal HSC commitment. We identified a total of 14,778 HSC commitment-associated DMRs (Supplementary Fig. 6c ), located mainly in CpG islands and isolated CpGs, and without a strong 'preference' for intergenic or intragenic regions (Supplementary Fig. 6d ). When we compared those normal HSC commitment-associated DMRs with the DMRs identified in Satb1 −/− HSCs, we found a significant overlap (P = 1.2 × 10 −37 by hypergeometrical testing), with 37% shared hypermethylated DMRs and 15% shared hypomethylated DMRs (overall, 22% shared DMRs; Supplementary Fig. 6e ).
We further evaluated whether methylation changes were accompanied by gene-expression changes in Satb1 −/− HSCs and found a set of 67 genes with substantial alterations in both expression and methylation in the vicinity of the gene (Supplementary Table 3) . Ingenuity pathway analysis showed enrichment in several functionally relevant networks ( Supplementary Fig. 6f and Supplementary  Table 4) . Notably, among those was a subset of genes (Itpr1 and Tnik) that encode molecules with known roles in cell cycle and cellular assembly 38, 39 , whose difference in expression in Satb1 −/− HSCs we had confirmed (Supplementary Fig. 4b ). Together these data showed that Satb1 acted as an epigenetic regulator in HSCs by modulating histone marks and DNA cytosine methylation, and indicated that Satb1 deficiency led to a commitment-primed epigenetic state in HSCs.
DISCUSSION
The interaction between transcription-factor networks is a key mechanism of cell-fate determination in pluripotent hematopoietic cells, including HSCs [40] [41] [42] . The biological outcome of the simultaneous activity of multiple transcriptional networks depends on the exact cellular and temporal context as HSCs commit and differentiate [40] [41] [42] . However, how transcriptional networks themselves are established and coordinately regulated in stem cells is still largely unknown. Our study has identified the chromatin-remodeling factor Satb1 as a regulator of transcriptional programs that 'instruct' quiescence, selfrenewal and commitment in HSCs.
Quiescent HSCs have superior long-term engraftment potential relative to that of actively cycling HSCs 24, 43 . Restriction of the cell cycling of HSCs prevents their premature depletion and hematopoietic failure under stress conditions 44 . Our study has shown that genes encoding molecules important for cell-cycle activation, including factors important in the transition from a quiescent stage (G0) to an active stage (G1), were derepressed in Satb1 −/− HSCs. Consistent with those findings, Satb1 −/− HSC populations were in a more activated state with significantly fewer cells in the G0 phase and more in the G1 phase of the cell cycle than were Satb1-expressing HSC populations. In contrast to G0, G1 is the cell-cycle phase in which intrinsic signals can influence cell fate. The integration and interpretation of transcriptional programs determine whether a cell enters S phase or pauses during G1 until the cell makes the 'decision' to self-renew, differentiate or undergo apoptosis 45 . The enhanced progression of Satb1 −/− HSCs into G1 may alter their likelihood to undergo cell-fate specification by making them more susceptible to differentiation commitmentinducing factors. Notably, Satb1 −/− HSCs had quantitatively greater generation of committed progenitor cells, which indicated that Satb1 was critical for suppressing HSC commitment and linked HSC quiescence with differentiation.
Chromatin-remodeling factors have been found to regulate cell fate in embryonic stem cells 39 and invertebrate stem cells 46 . We found that Satb1 −/− HSCs underwent significantly more symmetric commitment divisions at the expense of symmetric self-renewal divisions, whereas the rate of asymmetric divisions remained unchanged. Two Satb1-dependent gene networks were directly involved in the regulation of cellular polarity, differentiation and proliferation. In Satb1 −/− HSCs, expression of the genes encoding c-Myc and several of its transcriptional targets and the negative Notch regulator Numb was higher. Enforced expression or activation of c-Myc can lead to greater differentiation at the expense of self-renewal in HSCs 47 . Similarly, slightly higher Numb expression can also induce the differentiation of HSCs 29 , which suggests that Satb1 inhibits differentiation commitment at least in part through repression of Myc and Numb. Indeed, independent Numb and Myc 'rescue' experiments showed that the combination of a greater abundance of both c-Myc and Numb was critical for the enhanced commitment of Satb1 −/− HSC.
Numb is a segregating cell-fate determinant and tissue-specific repressor of the Notch pathway 30, 31 . Numb-mediated suppression of Notch in HSCs can induce differentiation 29 . We found that Satb1 negatively regulated Numb expression in HSCs and that Satb1 deficiency led to Numb-mediated inhibition of the expression of genes targeted by Notch. Impairment of the Notch target genes Hes1 and Hes5 in HSCs results in loss of HSCs and overproduction of myeloid progenitor cells 48 , consistent with the observed phenotype and results of functional 'rescue' experiments with Satb1 −/− HSCs. Restoration of Satb1 expression in Satb1 −/− HSCs led to normalization of the higher expression of Numb and significantly higher expression of Hes1. Furthermore, restoration of Numb expression normalized the expression of Hes1, Hes5 and Dtx1 and 'rescued' the greater colony-initiating capacity of Satb1 −/− HSCs. These data showed that in the absence of Satb1, higher expression of Numb mediated the decrease in symmetrical self-renewal divisions and the concomitant greater production of MPPs, which ultimately depleted the pool of Satb1 −/− HSCs.
In T cells, Satb1 binds to the Myc promoter and 'instructs' histone modifications 21 . We found that Satb1 bound to the promoters of both Numb and Myc in HPC7 cells, and restoration of Satb1 expression in Satb1 −/− HSCs 'rescued' the higher expression of Numb and Myc. Those observations, together with the finding of higher expression of Numb and Myc in Satb1 −/− HSCs, indicated that both Numb and c-Myc were downstream of Satb1. It is possible that this regulatory function of Satb1 is indirect and that cofactors are required.
Satb1 acts as an epigenetic regulator and chromatin organizer in T cells and erythroid cells 20 and is accompanied by alterations in histone modifications 16 . Our data showed that in Satb1 −/− HSCs, the absence of Satb1 resulted in a greater abundance of permissive H3K4me3 mark at the promoters both Numb and Myc. In addition, the DNA cytosine methylation patterns in Satb1 −/− HSCs were significantly different from those of wild-type HSCs; the patterns in Satb1 −/− HSCs resembled those of wild-type MPPs and indicated a 'commitment-primed' epigenetic state of Satb1 −/− HSCs. Those findings further supported our observation of greater differentiation commitment and less self-renewal of Satb1 −/− HSCs and showed that Satb1 acted as an epigenetic regulator in HSCs by modulating histone marks and DNA cytosine methylation.
Impairment of Satb1 activity is associated with a subset of patients with acute myeloid leukemia 15 . Moreover, myeloid-biased hematopoiesis has been noted in mouse loss-of-function models of positive Notch regulators, and loss-of-function mutations in the Notch pathway have been identified in patients with chronic myelomonocytic leukemia, npg A r t i c l e s consistent with the possibility that the myeloid-differentiation commitment of HSCs is enhanced by lower Notch activity 49 . This suggests a possible role for inactivation of Satb1 in stem cells and progenitor cells in the pathogenesis of leukemia. As Satb1 is important for the epithelial-mesenchymal transition, and a greater abundance of Satb1 has been found in epithelial tumors 17, 50 , it will be of interest to determine whether Satb1, similar to its function in hematopoietic stem cells, modulates cell polarity and self-renewal in tumor stem cells and may thereby offer new opportunities for targeted therapy. In summary, our study has demonstrated that Satb1 critically modulated HSC fate 'decisions' by acting as a regulator of several functionally linked HSC properties. Our data showed that Satb1 was crucial for sustained HSC self-renewal by simultaneously governing gene networks that control cell fate, promoting quiescence and repressing lineage commitment in HSCs.
METHODS
Methods and any associated references are available in the online version of the paper.
